Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 0.00% is 100% above its 5-year average of -2007.20%, near the high end of its 5-year range (-54866.67%–0.00%).
As of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
-1164.15%
NET PROFIT MARGIN AVG 5Y
-2007.20%
NET PROFIT MARGIN AVG 10Y
-2653.58%
NET PROFIT MARGIN AVG 15Y
-1391.35%
NET PROFIT MARGIN AVG 20Y
-899.81%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
+100.00%
CURRENT VS 5Y AVG
+100.00%
CURRENT VS 10Y AVG
+100.00%
CURRENT VS 15Y AVG
+100.00%
CURRENT VS 20Y AVG
+100.00%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 507 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
BioCardia, Inc.
Market Cap
$16.37M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
-1164.15%
5Y Avg
-2007.20%
Market Cap
$16.41M
Net Profit Margin
-106.58%
TTM Avg
-228.29%
3Y Avg
-394.31%
5Y Avg
-410.59%
Market Cap
$15.63M
Net Profit Margin
-3575.07%
TTM Avg
-1754.85%
3Y Avg
-877.42%
5Y Avg
-584.95%
Market Cap
$17.24M
Net Profit Margin
-219.50%
TTM Avg
-381.91%
3Y Avg
-332.62%
5Y Avg
-409.39%
Market Cap
$15.30M
Net Profit Margin
-3011.52%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-79.84%
Market Cap
$15.54M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
-2405.08%
Market Cap
$15.66M
Net Profit Margin
-153.28%
TTM Avg
-93.42%
3Y Avg
-97.51%
5Y Avg
-105.13%
Market Cap
$14.28M
Net Profit Margin
-651.27%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$18.54M
Net Profit Margin
-33.08%
TTM Avg
-29.53%
3Y Avg
-30.32%
5Y Avg
-22.32%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| BioCardia, Inc. (BCDA) | $16.37M | 0.00% | 0.00% | -1164.15% | -2007.20% |
| Bionano Genomics, Inc. (BNGO)vs › | $16.41M | -106.58% | -228.29% | -394.31% | -410.59% |
| Allarity Therapeutics, Inc. (ALLR)vs › | $15.63M | -3575.07% | -1754.85% | -877.42% | -584.95% |
| Dyadic International, Inc. (DYAI)vs › | $17.24M | -219.50% | -381.91% | -332.62% | -409.39% |
| Cocrystal Pharma, Inc. (COCP)vs › | $15.30M | -3011.52% | 0.00% | 0.00% | -79.84% |
| Pasithea Therapeutics Corp. (KTTA)vs › | $15.54M | 0.00% | 0.00% | 0.00% | -2405.08% |
| Karyopharm Therapeutics Inc. (KPTI)vs › | $15.66M | -153.28% | -93.42% | -97.51% | -105.13% |
| Citius Pharmaceuticals, Inc. (CTXR)vs › | $14.28M | -651.27% | 0.00% | 0.00% | 0.00% |
| Cosmos Health Inc. (COSM)vs › | $18.54M | -33.08% | -29.53% | -30.32% | -22.32% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.77M | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | -54866.67% |
| 2024-03-31 | -4121.82% |
| 2023-12-31 | -15938.46% |
| 2023-09-30 | -721.01% |
| 2023-06-30 | -7962.79% |
| 2023-03-31 | -5470.31% |
| 2022-12-31 | -2856.60% |
| 2022-09-30 | -1441.98% |
| 2022-06-30 | -256.37% |
| 2022-03-31 | -5541.67% |
| 2021-12-31 | -4381.01% |
| 2021-09-30 | -329.60% |
| 2021-06-30 | -5053.62% |
| 2021-03-31 | -6454.35% |
| 2020-12-31 | -6497.83% |
| 2020-09-30 | -11317.65% |
| 2020-06-30 | -13233.33% |
| 2020-03-31 | -12089.47% |
| 2019-12-31 | -1628.37% |
| 2019-09-30 | -1954.64% |
| 2019-06-30 | -4360.47% |
| 2019-03-31 | -1696.76% |
| 2018-12-31 | -3535.92% |
| 2018-09-30 | -4219.05% |
| 2018-06-30 | -1346.03% |
| 2018-03-31 | -1801.01% |
| 2017-12-31 | -3486.00% |
| 2017-09-30 | -2308.46% |
| 2017-06-30 | -2629.46% |
| 2017-03-31 | -2099.27% |
| 2016-12-31 | 295.56% |
| 2016-09-30 | 4376.92% |
| 2016-06-30 | 52.82% |
| 2016-03-31 | 55.03% |
| 2015-12-31 | 66.67% |
| 2015-09-30 | 68.60% |
| 2015-06-30 | 58.40% |
| 2015-03-31 | 55.88% |
| 2014-12-31 | 47.66% |
| 2014-09-30 | 44.79% |
| 2014-06-30 | 62.86% |
| 2014-03-31 | 65.31% |
| 2013-12-31 | 5.56% |
| 2013-09-30 | 42.25% |
| 2013-06-30 | 13.04% |
| 2013-03-31 | -65.79% |
| 2012-12-31 | 253.33% |
| 2012-09-30 | 2373.68% |
| 2012-06-30 | -758.82% |
| 2012-03-31 | -500.00% |
| 2011-12-31 | -2375.00% |
| 2011-09-30 | 0.00% |
| 2011-06-30 | 0.00% |
| 2011-03-31 | 0.00% |
| 2010-12-31 | 16.69% |
| 2010-09-30 | -1052.27% |
| 2010-06-30 | -137.60% |
| 2010-03-31 | -161.31% |
| 2009-12-31 | -236.04% |
| 2009-09-30 | -276.38% |
| 2009-06-30 | -300.22% |
| 2009-03-31 | -283.33% |
| 2008-12-31 | -677.98% |
| 2008-09-30 | -300.49% |
| 2008-06-30 | 0.00% |
| 2008-03-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-09-30 | 0.00% |
| 2007-06-30 | 0.00% |
| 2007-03-31 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-09-30 | 0.00% |
| 2006-06-30 | 0.00% |
| 2006-03-31 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-09-30 | 0.00% |
| 2005-06-30 | 0.00% |
| 2005-03-31 | 0.00% |
| 2004-12-31 | -6.04% |
| 2004-09-30 | -23.36% |
| 2004-06-30 | -15.49% |
| 2004-03-31 | -26.18% |
| 2003-12-31 | -25.84% |
| 2003-09-30 | -11.24% |
| 2003-06-30 | 4.53% |
| 2003-03-31 | -24.80% |
| 2002-12-31 | -11.85% |
| 2002-09-30 | -21.04% |
